Metagenomi Therapeutics Inc
(MGX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2023 | 12-2022 | 12-2021 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 0 | 184,441 | 39,296 |
| Marketable Securities | 0 | 177,690 | 68,858 |
| Other current assets | 0 | 4,768 | 762 |
| TOTAL | $0 | $366,899 | $108,916 |
| Non-Current Assets | |||
| PPE Net | N/A | 18,770 | 4,415 |
| Investments And Advances | 0 | 7,806 | 6,417 |
| Other Non-Current Assets | 0 | 6,523 | 4,769 |
| TOTAL | $N/A | $33,099 | $15,601 |
| Total Assets | $0 | $414,486 | $141,992 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 0 | 2,011 | 1,354 |
| Accrued Expenses | 0 | 8,790 | 3,531 |
| Other current liabilities | 0 | 34,685 | 19,600 |
| TOTAL | $0 | $48,537 | $25,172 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 0 | 1,033 | 31,188 |
| TOTAL | $N/A | $77,218 | $54,904 |
| Total Liabilities | $0 | $142,811 | $98,041 |
| Shareholders' Equity | |||
| Common Shares | 0 | 26 | 26 |
| Retained earnings | 0 | -76,689 | -33,096 |
| Other shareholders' equity | 0 | 348,338 | 77,021 |
| TOTAL | $0 | $271,675 | $43,951 |
| Total Liabilities And Equity | $0 | $414,486 | $141,992 |